Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy. (1st April 2023)

• Record Type: Journal Article
• Authors: Ben-Akiva, Elana; Hickey, John W.; Meyer, Randall A.; Isser, Ariel; Shannon, Sydney R.; Livingston, Natalie K.; Rhodes, Kelly R.; Kosmides, Alyssa K.; Warren, Tiarra R.; Tzeng, Stephany Y.; Schneck, Jonathan P.; Green, Jordan J.
• Is Part Of: Acta biomaterialia. Volume 160(2023)
• Page Start: 187
• Page End: 197
• Publication Date: 2023-04-01
• Subjects: Artificial antigen presenting cell -- Nanoparticle shape -- Cancer -- Immunoengineering -- Biomimetic; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2023.02.023
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Artificial antigen presenting cells are biomimetic particles that recapitulate the signals presented by natural antigen presenting cells in order to stimulate T cells in an antigen-specific manner using an acellular platform. We have engineered an enhanced nanoscale biodegradable artificial antigen presenting cell by modulating particle shape to achieve a nanoparticle geometry that allows for increased radius of curvature and surface area for T cell contact. The non-spherical nanoparticle artificial antigen presenting cells developed here have reduced nonspecific uptake and improved circulation time compared both to spherical nanoparticles and to traditional microparticle technologies. Additionally, the anisotropic nanoparticle artificial antigen presenting cells efficiently engage with and activate T cells, ultimately leading to a marked anti-tumor effect in a mouse melanoma model that their spherical counterparts were unable to achieve. Statement of significance: Artificial antigen presenting cells (aAPC) can activate antigen-specific CD8+ T cells but have largely been limited to microparticle-based platforms and ex vivo T cell expansion. Although more amenable to in vivo use, nanoscale aAPC have traditionally been ineffective due to limited surface area available for T cell interaction. In this work, we engineered non-spherical biodegradable nanoscale aAPC to investigate the role of particle geometry and develop a translatable platform for T cell activation. The non-spherical aAPC developed here have increased surface area and a flatter surface for T cell engagement and, therefore, can more effectively stimulate antigen-specific T cells, resulting in anti-tumor efficacy in a mouse melanoma model. Graphical abstract: Image, graphical abstract